Morse Asset Management’s Emergent Biosolutions EBS Stock Holding History

Morse Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.84M	Sell	221,799 -7,509	-3%	-$77.8K	0.38%	63
2025 Q4	$2.83M	Buy	229,308 +11,383	+5%	+$122K	0.57%	52
2025 Q3	$1.92M	Buy	217,925 +9,881	+5%	+$76.9K	0.38%	65
2025 Q2	$1.33M	Buy	208,044 +20,580	+11%	+$118K	0.29%	77
2025 Q1	$911K	Buy	187,464 +28,645	+18%	+$237K	0.23%	83
2024 Q4	$1.52M	Buy	+158,819	New	+$1.46M	0.35%	66
2024 Q3	–	Sell	-14,200	Closed	-$97K	–	345
2024 Q2	$97K	Buy	+14,200	New	+$61.1K	0.02%	142
2019 Q1	–	Sell	-27,050	Closed	-$1.6M	–	130
2018 Q4	$1.6M	Buy	27,050 +2,950	+12%	+$190K	0.57%	48
2018 Q3	$1.59M	Hold	24,100	–	–	0.42%	69
2018 Q2	$1.22M	Buy	24,100 +11,180	+87%	+$582K	0.33%	75
2018 Q1	$680K	Buy	+12,920	New	+$644K	0.19%	96

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morse Asset Management's EBS Position: Q1 2026 in Review

Morse Asset Management reduced its Emergent Biosolutions (EBS) stake by 3.3% in Q1 2026, selling an estimated $77.8K and leaving 221,799 shares worth $1.84M. The position accounts for 0.38% of the portfolio, ranked #63.

Morse Asset Management first reported a position in EBS in Q1 2018 and has held it in 11 quarters since. The position peaked at $2.83M in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

Morse Asset Management held 221,799 shares of Emergent Biosolutions worth $1.84M as of Q1 2026.
Morse Asset Management sold 7,509 Emergent Biosolutions shares in Q1 2026, an estimated $77.8K.
Emergent Biosolutions made up 0.38% of Morse Asset Management's portfolio in Q1 2026, its #63 holding.
Morse Asset Management first reported a position in Emergent Biosolutions in Q1 2018 and has held it in 11 quarters since.
Morse Asset Management's Emergent Biosolutions position peaked at $2.83M in Q4 2025.
190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Morse Asset Management's 13F filing for Q1 2026, filed 14 May 2026.